Ambac Financial Group, Inc. — Form 10-Q Summary
Filing identity: The source filing identifies the registrant as Ambac Financial Group, Inc., not Octave Specialty Group Inc. It covers the quarter ended March 31, 2015, filed May 11, 2015. The financial statements are unaudited and prepared under U.S. GAAP.
Business context and reporting period
Ambac is a financial services holding company with two reportable segments: Financial Guarantee and Financial Services. The financial guarantee business is in runoff and is generally unable to write new business because of losses in its insured portfolio. Financial Services activities, including investment agreements and derivatives, are also in active runoff.
Ambac Assurance Corporation’s Segregated Account remains subject to Wisconsin rehabilitation proceedings. Management stated that substantial doubt exists regarding Ambac’s ability to continue as a going concern, although the financial statements were prepared on a going-concern basis without related adjustments.
Key financial metrics
| Metric | Q1 2015 | Q1 2014 / March 31, 2014 | Change |
|---|---|---|---|
| Total revenues | $155.5 million | $109.1 million | Up $46.4 million |
| Net premiums earned | $65.7 million | $82.5 million | Down 20.4% |
| Net investment income | $73.0 million | $70.8 million | Up $2.2 million |
| Net realized investment gains | $54.1 million | $16.3 million | Up $37.8 million |
| Losses and loss expenses | $(151.0) million benefit | $(140.0) million benefit | Larger benefit by $11.0 million |
| Pre-tax income | $216.6 million | $159.3 million | Up 35.9% |
| Net income attributable to common shareholders | $214.7 million | $155.9 million | Up 37.7% |
| Diluted earnings per share | $4.57 | $3.31 | Up $1.26 |
| Operating earnings, non-GAAP | $247.6 million | $176.6 million | Up $71.0 million |
| Adjusted book value, non-GAAP | $479.0 million | $337.4 million at Dec. 31, 2014 | Up $141.6 million |
At March 31, 2015, total assets were $25.4 billion, total liabilities were $23.5 billion, and total stockholders’ equity was $1.84 billion. Ambac Financial Group stockholders’ equity was $1.56 billion. Cash and cash equivalents were $26.6 million, while short-term investments were $221.0 million.
Long-term debt was $979.0 million at the parent and consolidated operating-company level, excluding $13.34 billion of long-term debt reported for consolidated variable interest entities. Accrued interest payable was $322.4 million, and non-VIE derivative liabilities were $447.4 million.
Cash flow, liquidity and capital
- Operating activities provided $5.6 million of cash, compared with $38.5 million in Q1 2014.
- Investing activities used $3.0 million, compared with $84.2 million used in Q1 2014.
- Financing activities used $49.9 million, primarily for investment agreement draws.
- Net cash flow was negative $47.3 million, reducing cash from $73.9 million at December 31, 2014 to $26.6 million at March 31, 2015.
- Ambac Financial Group’s liquidity depends principally on cash, liquid investments, expense-sharing arrangements and potential NOL-related payments. Ambac Assurance dividends are highly unlikely for the foreseeable future.
- Ambac Assurance’s statutory policyholder surplus was $100.0 million, equal to the required minimum surplus amount. The Segregated Account had $362.0 million of statutory policyholder surplus.
- Ambac Assurance had $3.30 billion of Segregated Account claims remaining unpaid, including $369.1 million of accrued interest on Deferred Amounts.
- Ambac posted $108.4 million of collateral related to investment agreements and $260.5 million of net collateral or margin under Financial Services derivatives.
Material changes versus the prior comparable period
- Net income increased substantially, primarily because of higher realized investment gains, lower derivative product losses, a larger loss-reserve benefit and improved income from consolidated VIEs.
- Premium revenue declined because the insured portfolio continues to run off through maturities, calls, terminations and commutations.
- Net realized investment gains increased to $54.1 million, primarily from sales of Ambac-wrapped student loan securities associated with a financial guarantee commutation.
- Derivative product losses improved to $37.8 million from $53.8 million, although lower interest rates increased the fair value of derivative liabilities.
- Loss and loss expense reserves declined to $3.49 billion from $3.80 billion at year-end 2014. Positive prior-year development reflected improved RMBS performance, lower interest rates, commutations and higher estimated recoveries.
- Guaranteed net par outstanding declined to $136.8 billion from $144.7 billion at December 31, 2014. Below-investment-grade exposure represented 18% of the guaranteed portfolio, compared with 17% at year-end.
- Total stockholders’ equity increased by approximately $164 million, primarily reflecting comprehensive income, despite a $51.3 million decline in other comprehensive income during the quarter.
- The net insurance intangible asset declined to $1.35 billion from $1.41 billion after $37.4 million of quarterly amortization.
Guidance, outlook, risks and unusual items
The filing does not provide formal quantitative earnings guidance. Management’s strategy is to maximize value from Ambac Assurance through asset and liability management, policy commutations, recoveries, litigation and possible restructuring or monetization transactions, while selectively exploring new financial services opportunities.
- Going concern: Management identified substantial doubt about the company’s ability to continue as a going concern, principally because of rehabilitation oversight and uncertainty regarding Ambac Assurance’s ability to deliver value or liquidity to the parent.
- Rehabilitation and regulatory control: The Rehabilitator acts for policyholders and can control or approve significant actions affecting the Segregated Account. Future claim payments and Deferred Amount payments are subject to applicable approvals and discretion.
- Reserve sensitivity: Management estimated reasonably possible additional loss reserves of approximately $133 million for RMBS, $356 million for student loans, $1.803 billion for public finance and $514 million for other credits, including Ambac UK, under stated stress scenarios. These are stress estimates, not forecasts.
- Recovery uncertainty: The company carried approximately $2.6 billion of RMBS representation-and-warranty subrogation recoveries. Actual recoveries depend on litigation outcomes, counterparty solvency, contractual interpretations and regulatory intervention.
- Portfolio and credit risk: The investment portfolio included $2.48 billion of mortgage and asset-backed securities, with a weighted-average rating of CC for the mortgage and asset-backed portfolio. Interest rates, credit spreads, foreign exchange, defaults and fair-value model assumptions may materially affect results.
- Derivative contingencies: Ambac Assurance’s credit ratings have been withdrawn, triggering collateral and termination provisions in many derivative and investment agreement contracts. Potential CDS termination payments were estimated at $117.2 million, although a rehabilitation-court injunction restricts certain early terminations.
- Ambac UK: Ambac UK reported a shareholder-funds deficit of £59.6 million under UK GAAP and a regulatory capital deficiency of £381.8 million. Management stated that regulators are aware and discussions remain ongoing.
- Litigation: Ambac and its subsidiaries remain involved in litigation involving municipalities, RMBS sponsors, underwriters and other counterparties. Outcomes and recoveries are uncertain and could materially affect cash flows and reserves.
Most important facts for an investor to verify
- Confirm the registrant identity, because the supplied metadata names Octave Specialty Group Inc. while the filing names Ambac Financial Group, Inc.
- Review the going-concern disclosure and the extent to which parent liquidity depends on restricted or uncertain upstream payments.
- Assess the sustainability of Q1 earnings, which benefited materially from realized investment gains, fair-value changes and favorable reserve development rather than recurring premium growth.
- Reconcile gross insurance exposures, loss reserves and the approximately $2.6 billion of estimated RMBS recoveries, including the litigation and collectability assumptions.
- Evaluate the rehabilitation plan, Deferred Amounts, accrued interest and the possibility of increased policyholder payments or further regulatory proceedings.
- Review the stress-case reserve sensitivities, particularly the public finance and student loan scenarios.
- Examine collateral requirements, derivative termination rights and the effect of interest-rate and credit-spread movements on liquidity and fair values.
- Monitor Ambac UK’s regulatory capital deficiency and the status of discussions with UK regulators.